
Allows CDMO to enhance its therapeutic and vaccine offerings

Advanco provides software solution architecture and configuration while Vantage delivers design, implementation, and validation services

The Advanced Pharmaceutical Manufacturing (APM) Cluster, led by the Virginia Biotechnology Research Partnership Authority (Activation Capital), secures almost $53 million from the EDA’s Build Back Better Regional Challenge to boost Virginia’s pharmaceutical industry

Location expands company’s pharmacovigilance, regulatory affairs services

Shots target Omicron's BA.4 and BA.5 subvariants

Will feature additional cell and gene therapy capacity

Collaboration expected to accelerate the bionnovative drug R&D process

The latest people news happenings over the past month

Massachusetts facility will support biologics developers in the New England area

Illinois branch makes it the company's sixth new location in 2022

Company’s Conroe location will serve as HQ

If authorized by FDA, will arrive in time for possible fall and winter surges

CDMO’s 76,000 square-foot manufacturing center will be commercial ready

Track-and-trace provider will be incorporating fingerprinting tech into its line

CDMO filling capacity now exceeds 50 million units yearly

Company’s 344,000 square-foot facility revolves around pharma and medical items

Partnership adds technological offerings to PharmaLex’s repertoire

Site expected to boost the CDMO’s global drug production capabilities

The shot targets the original variant, along with Omicron

Agreement is centered around expanding medication access to patients

In deal to be finalized by October, purchases B Medical Systems for $423 million

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity

Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity

Acquisition of healthcare logistics company to play a role in delivery of pharma and biologic treatments

Multi-year deal aims to put patients at the center of their clinical data

Association’s director general recommends air cargo developments be closely monitored in second half of year

New facility will provide lyophilization services

Division will operate under SCHOTT Pharma AG & Co. KGaA

Price tag for bivalent dose was $1.74 billion